1. Home
  2. Stocks
  3. Jublpharma Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Jubilant Pharmova Share Price

    Mid Cap
    ₹951.65
    + 13.95 (1.49%)
    08 September, 2024 06:06 BSE: 530019 NSE: JUBLPHARMA ISIN: INE700A01033

    Start SIP in Jubilant Pharmova

    Start SIP

    Jubilant Pharmova Performance

    Day Range

    • Low 935
    • High 970
    ₹ 951

    52 Week Range

    • Low 319
    • High 970
    ₹ 951
    • Open Price966
    • Previous Close938
    • Volume695261

    Jubilant Pharmova Chart

    • Over 1 Month + 11.97%
    • Over 3 Month + 32.08%
    • Over 6 Month + 59.14%
    • Over 1 Year + 109.59%

    Jubilant Pharmova Key Statistics

    P/E Ratio 27.4
    PEG Ratio 0
    Market Cap Cr
    Price to Book Ratio 2.8
    EPS 2
    Dividend 0.5
    Relative Strength Index 72.47
    Money Flow Index 79.08
    MACD Signal 36.08
    Average True Range 30.91

    Jubilant Pharmova Investment Rating

    • Master Rating:

    • Jubilant Pharmova has an operating revenue of Rs. 6,847.70 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a debt to equity of 58%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 43% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Jubilant Pharmova Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 163202170186204189
    Operating Expenses Qtr Cr 166194176186213198
    Operating Profit Qtr Cr 112-1142
    Depreciation Qtr Cr 131312121111
    Interest Qtr Cr 888766
    Tax Qtr Cr -1901030
    Net Profit Qtr Cr -1033-202-31
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 888948
    Operating Expenses Annual Cr 768807
    Operating Profit Annual in Cr 173
    Depreciation Cr 4843
    Interest Annual Cr 3019
    Tax Annual Cr 1029
    Net Profit Annual Cr 3250
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 143-65
    Cash from Investing Activity Annual Cr -4031
    Cash from Financing Annual Activity Cr -7823
    Net Cash Flow Annual Cr 25-12
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,3752,415
    Fixed Assets Annual Cr 748734
    Total Non Current Assets Annual Cr 2,4512,430
    Total Current Assets Annual Cr 541579
    Total Assets Annual Cr 2,9923,008
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 149152
    ROE Annual % 12
    ROCE Annual % 34
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1517
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,7201,7461,6651,6671,5671,661
    Operating Expenses Qtr Cr 1,4801,4871,4591,4391,4171,459
    Operating Profit Qtr Cr 252271218242170219
    Depreciation Qtr Cr 91101959790271
    Interest Qtr Cr 717371666256
    Tax Qtr Cr 18835361914
    Net Profit Qtr Cr 482-5967636-98
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 6,7726,320
    Operating Expenses Annual Cr 5,8025,505
    Operating Profit Annual in Cr 901776
    Depreciation Cr 382554
    Interest Annual Cr 272188
    Tax Annual Cr 9893
    Net Profit Annual Cr 77-61
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 971661
    Cash from Investing Activity Annual Cr -608-544
    Cash from Financing Annual Activity Cr -433-157
    Net Cash Flow Annual Cr -69-40
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 5,4345,399
    Fixed Assets Annual Cr 4,7304,316
    Total Non Current Assets Annual Cr 7,6727,394
    Total Current Assets Annual Cr 3,8763,762
    Total Assets Annual Cr 11,54911,157
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 343339
    ROE Annual % 1-1
    ROCE Annual % 63
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1413
    Invest in Jubilant Pharmova

    Jubilant Pharmova Technicals

    EMA & SMA

    Current Price
    ₹951.65
    + 13.95 (1.49%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹898.15
    • 50 Day
    • ₹835.92
    • 100 Day
    • ₹768.55
    • 200 Day
    • ₹677.40
    • 20 Day
    • ₹901.53
    • 50 Day
    • ₹815.65
    • 100 Day
    • ₹759.61
    • 200 Day
    • ₹654.43

    Jubilant Pharmova Resistance and Support

    PIVOT
    ₹952.19
    Resistance
    First Resistance 969.37
    Second Resistance 987.08
    Third Resistance 1,004.27
    RSI 72.47
    MFI 79.08
    MACD Single Line 36.08
    MACD 34.93
    Support
    First Support 934.47
    Second Support 917.28
    Third Supoort 899.57

    Jubilant Pharmova Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 734,169 25,343,514 34.52
    Week 375,516 17,191,122 45.78
    1 Month 428,605 15,986,977 37.3
    6 Month 546,570 17,052,977 31.2

    Jubilant Pharmova Result Highlights

    Jubilant Pharmova Synopsis

    NSE-Medical-Diversified

    Jubilant Pharmova is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 784.70 Cr. and Equity Capital is Rs. 15.90 Cr. for the Year ended 31/03/2024. Jubilant Pharmova Ltd. is a Public Limited Listed company incorporated on 21/06/1978 and has its registered office in the State of Uttar Pradesh, India. Company’s Corporate Identification Number(CIN) is L24116UP1978PLC004624 and registration number is 004624.
    Market Cap 15,158
    Sales 734
    Shares in Float 7.80
    No of funds 156
    Yield 0.53
    Book Value 6.37
    U/D Vol ratio 2.9
    LTDebt / Equity 10
    Alpha 0.22
    Beta 1

    Jubilant Pharmova Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 50.68%50.68%50.68%50.68%
    Mutual Funds 2.25%2.27%1.5%0.42%
    Insurance Companies
    Foreign Portfolio Investors 19.5%19.06%20.29%23.2%
    Financial Institutions/ Banks
    Individual Investors 17.78%18.72%18.75%18.24%
    Others 9.79%9.27%8.78%7.46%

    Jubilant Pharmova Management

    Name Designation
    Mr. Shyam S Bhartia Chairman
    Mr. Hari S Bhartia Co-Chairman
    Mr. Priyavrat Bhartia Managing Director
    Mr. Arjun Shanker Bhartia Joint Managing Director
    Mr. Arvind Chokhany WholeTime Director & Group CFO
    Dr. Ramakrishnan Arul Whole Time Director
    Mr. Shirish G Belapure Independent Director
    Mr. Sushil Kumar Roongta Independent Director
    Mr. Vivek Mehra Independent Director
    Mr. Arun Seth Independent Director
    Dr. Harsh Mahajan Independent Director
    Ms. Shivpriya Nanda Independent Director

    Jubilant Pharmova Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Jubilant Pharmova Corporate Action

    Date Purpose Remarks
    2024-07-19 Quarterly Results
    2024-05-29 Audited Results & Final Dividend
    2024-02-02 Quarterly Results
    2023-10-27 Quarterly Results
    2023-07-19 Quarterly Results
    Date Purpose Remarks
    2024-08-02 FINAL Rs.5.00 per share(500%)Final Dividend
    2023-08-10 FINAL Rs.5.00 per share(500%)Final Dividend
    2022-08-12 FINAL Rs.5.00 per share(500%)Final Dividend
    2021-08-06 FINAL Rs.5.00 per share(500%)Final Dividend

    Jubilant Pharmova MF Shareholding

    Name Amount(cr)
    Quant Small Cap Fund Growth 25,535
    Nippon India Pharma Fund - Growth 8,648
    Quant Flexi Cap Fund Growth 7,710
    Motilal Oswal Nifty 500 Fund Regular Growth 1,991
    Nippon India Nifty Smallcap 250 Index Fund Reg Gr 1,715

    Jubilant Pharmova FAQs

    What is Share Price of Jubilant Pharmova ?

    Jubilant Pharmova share price is ₹951 As on 08 September, 2024 | 05:52

    What is the Market Cap of Jubilant Pharmova ?

    The Market Cap of Jubilant Pharmova is ₹15158 Cr As on 08 September, 2024 | 05:52

    What is the P/E ratio of Jubilant Pharmova ?

    The P/E ratio of Jubilant Pharmova is 27.4 As on 08 September, 2024 | 05:52

    What is the PB ratio of Jubilant Pharmova ?

    The PB ratio of Jubilant Pharmova is 2.8 As on 08 September, 2024 | 05:52

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.